相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy
C. A. Greig et al.
SUPPORTIVE CARE IN CANCER (2014)
Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model
Si-Zeng Chen et al.
TUMOR BIOLOGY (2014)
Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
Carla M. Prado et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia
Katie M. Di Sebastiano et al.
BRITISH JOURNAL OF NUTRITION (2013)
Optimization of the systemic inflammation-based Glasgow Prognostic Score
Michael J. Proctor et al.
CANCER (2013)
Possible Role for Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia
Katsutoshi Ando et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prognostic Factors of Survival in Patients With Advanced Cancer Admitted to Home Care
Sebastiano Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2013)
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
Adrian S. Dobs et al.
LANCET ONCOLOGY (2013)
Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study
Jose M. Garcia et al.
SUPPORTIVE CARE IN CANCER (2013)
Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer
Sang-Yeon Suh et al.
SUPPORTIVE CARE IN CANCER (2013)
Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model
R. Northrup et al.
SUPPORTIVE CARE IN CANCER (2013)
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Kenneth C. H. Fearon et al.
CELL METABOLISM (2012)
Role of Ca2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle
K. A. Mirza et al.
CELLULAR SIGNALLING (2012)
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life
Antonio Maccio et al.
GYNECOLOGIC ONCOLOGY (2012)
Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia
Jochen Springer et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients
Yuan-Shui Sun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Pathophysiological Role of Hormones and Cytokines in Cancer Cachexia
Hyun Jung Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
A Phase II Dose Titration Study of Thalidomide for Cancer-Associated Anorexia
Mellar Davis et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2012)
The Role of Thalidomide and Placebo for the Treatment of Cancer-Related Anorexia-Cachexia Symptoms: Results of a Double-Blind Placebo-Controlled Randomized Study
Sriram Yennurajalingam et al.
JOURNAL OF PALLIATIVE MEDICINE (2012)
C-Reactive Protein Levels and Vitamin D Receptor Polymorphisms as Markers in Predicting Cachectic Syndrome in Cancer Patients
Tiziana Punzi et al.
MOLECULAR DIAGNOSIS & THERAPY (2012)
Adipokines and Systemic Inflammation in Weight-Losing Lung Cancer Patients
Sule T. Gulen et al.
LUNG (2012)
The Endocannabinoid System: Role in Energy Regulation
Thomas F. Gamage et al.
PEDIATRIC BLOOD & CANCER (2012)
Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency
Cloe M. Julienne et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2012)
Obestatin: An Interesting but Controversial Gut Hormone
Antonio Lacquaniti et al.
ANNALS OF NUTRITION AND METABOLISM (2011)
Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
Shontelle Dodson et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Poor tolerability of thalidomide in end-stage oesophageal cancer
E. A. Wilkes et al.
EUROPEAN JOURNAL OF CANCER CARE (2011)
New aspects of melanocortin signaling: A role for PRCP in alpha-MSH degradation
Sabrina Diano
FRONTIERS IN NEUROENDOCRINOLOGY (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Survival Prediction for Terminally Ill Cancer Patients: Revision of the Palliative Prognostic Score with Incorporation of Delirium
Emanuela Scarpi et al.
ONCOLOGIST (2011)
The cachexia score (CASCO): a new tool for staging cachectic cancer patients
Josep M. Argiles et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2011)
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
James T. Dalton et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2011)
Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting
Norleena P. Gullett et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
Vickie E. Baracos et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Megestrol acetate in cancer anorexia and weight loss
N. Simon Tchekmedyian et al.
CANCER (2010)
Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey
Niyati Parekh et al.
CANCER CAUSES & CONTROL (2010)
Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice
Michelle L. Asp et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
Giovanni Mantovani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
Aminah Jatoi et al.
LUNG CANCER (2010)
A tale of two hormones
Jeffrey M. Friedman
NATURE MEDICINE (2010)
Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer
Giovanni Mantovani et al.
ONCOLOGIST (2010)
Cancer cachexia: medical management
Giovanni Mantovani et al.
SUPPORTIVE CARE IN CANCER (2010)
Optimal management of cancer anorexia–cachexia syndrome
Jose Maria Argilés et al.
Cancer Management and Research (2010)
Decreased Jun-D and myogenin expression in muscle wasting of human cachexia
Sonia Ramamoorthy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate
S. T. Russell et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Medroxyprogesterone acetate in the management of cancer cachexia
Clelia Madeddu et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
ASPEN Clinical Guidelines: Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation
David Allen August et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2009)
Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients
Eleni M. Karapanagiotou et al.
LUNG CANCER (2009)
Origin and function of ubiquitin-like proteins
Mark Hochstrasser
NATURE (2009)
Cytokines and Cancer Anorexia Cachexia Syndrome
Nabila Bennani-Baiti et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2008)
Neural control of the anorexia-cachexia syndrome
Alessandro Laviano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa
Toshihiro Nakahara et al.
BIOLOGICAL PSYCHIATRY (2008)
Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers
Malgorzata Krzystek-Korpacka et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
The pathogenesis of cancer related fatigue: Could increased activity of pro-inflammatory cytokines be the common denominator?
A. Jager et al.
EUROPEAN JOURNAL OF CANCER (2008)
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Central blockade of melanocortin receptors attenuates the metabolic and locomotor responses to peripheral interleukin-1β administration
Keith W. Whitaker et al.
NEUROPHARMACOLOGY (2008)
An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
Donald C. McMillan
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Nutritional support in multimodal therapy for cancer cachexia
Ingvar Bosaeus
SUPPORTIVE CARE IN CANCER (2008)
IFN-γ does not mimic the catabolic effects of TNF-α
Melissa A. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
How relevant are cytokines in colorectal cancer wasting?
Paula Ravasco et al.
CANCER JOURNAL (2007)
Ghrelin attenuates sepsis-induced acute and mortality in rats
Rongqian Wu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia?: Role of β2-adrenergic agonists
Gemma Fuster et al.
CANCER RESEARCH (2007)
Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia
Mark D. DeBoer et al.
ENDOCRINOLOGY (2007)
Insulin treatment in cancer cachexia:: Effects on survival, metabolism, and physical functioning
Kent Lundholm et al.
CLINICAL CANCER RESEARCH (2007)
Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol
William O. Kline et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Cancer cachexia syndrome in head and neck cancer patients: Part I. Diagnosis, impact on quality of life and survival, and treatment
Marion Couch et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands
Wenqing Gao et al.
PHARMACEUTICAL RESEARCH (2006)
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group
Florian Strasser et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
On our way to targeted therapy for cachexia in cancer?
Manon S. A. Boddaert et al.
CURRENT OPINION IN ONCOLOGY (2006)
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Stewart H. Lecker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress
Giovanni Mantovani et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Therapeutic action of ghrelin in a mouse model of colitis
Elena Gonzalez-Rey et al.
GASTROENTEROLOGY (2006)
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients
I Wolf et al.
CANCER (2006)
Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia
Noritoshi Nagaya et al.
INTERNAL MEDICINE (2006)
Cancer cachexia
JN Gordon et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
Prognostic factors in advanced cancer patients:: Evidence-based clinical recommendations -: A study by the Steering Committee of the European Association for Palliative Care
M Maltoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
NF-κB-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release
S Di Marco et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Therapy Insight: cancer anorexia-cachexia syndrome - when all you can eat is yourself
A Laviano et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Supportive nutrition on recovery of metabolism, nutritional state, health-related quality of life, and exercise capacity after major surgery:: A randomized study
A Hyltander et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Systemic inflammation, cachexia and prognosis in patients with cancer
C Deans et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2005)
Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture:: integrated response to TNF-α
BH Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Therapy Insight: cancer anorexia-cachexia syndrome - when all you can eat is yourself
A Laviano et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer
A Ishikawa et al.
CLINICAL CANCER RESEARCH (2005)
PPARγ-mediated insulin sensitization:: the importance of fat versus muscle
U Kintscher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
β2-Adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury
F Beitzel et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Ghrelin - a hormone with multiple functions
M Korbonits et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2004)
Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects
T Akamizu et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Anticachectic effects of formoterol:: A drug for potential treatment of muscle wasting
S Busquets et al.
CANCER RESEARCH (2004)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
S Acharyya et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders - Review of efficacy and safety
R Orr et al.
DRUGS (2004)
Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3α-II during cancer cachexia
KS Kwak et al.
CANCER RESEARCH (2004)
Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial
NM Neary et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients
Y Miyazaki et al.
DIABETES (2003)
Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible
WA Banks et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Understanding and managing cancer cachexia
N MacDonald et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2003)
Differential role of melanocortin receptor subtypes in cachexia
DL Marks et al.
ENDOCRINOLOGY (2003)
Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans
H Staiger et al.
OBESITY RESEARCH (2003)
Plasma adiponectin concentrations in relation to endometrial cancer: A case-control study in Greece
E Petridou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The role of the novel adipocyte-derived hormone adiponectin in human disease
JJ Díez et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia
IG Makarenko et al.
BRAIN RESEARCH (2003)
Leptin: a review of its peripheral actions and interactions
S Margetic et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Peripheral mechanisms involved with catabolism
W Langhans
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2002)
Chronic clenbuterol administration negatively alters cardiac function
MM Sleeper et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2002)
The mode of action of thiazolidinediones
H Hauner
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism
AH Berg et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Cachexia in MAC16 adenocarcinoma: Suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y
C Bing et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Cytokines and feeding
C Plata-Salamán
INTERNATIONAL JOURNAL OF OBESITY (2001)
Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF)
B Islam-Ali et al.
BRITISH JOURNAL OF CANCER (2001)
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin
WS Yang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Attenuation of insulin resistance by chronic β2-adrenergic agonist treatment -: Possible muscle specific contributions
A Castle et al.
LIFE SCIENCES (2001)
Inhibition of NF-κB activity by thalidomide through suppression of IκB kinase activity
JA Keifer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Managing cancer-related anorexia/cachexia
G Mantovani et al.
DRUGS (2001)
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites
G Mantovani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2000)
分享论文
